18 Sep 2012, BioSpectrum Bureau , BioSpectrum
Bangalore: Indian firm Venus Remedies has won Manufacturing Leadership Award for its world-class manufacturing and operational excellence at the Industry 2.0 Manufacturing Innovation Conclave 2012.
Venus's three manufacturing facilities have 15 national and international GMP certifications to their credit, which include EU-GMP, WHO-GMP, GCC-GMP and Latin American GMP (INVIMA). The company has marked itself in the niche segment of 'critical care' in antibiotic, oncology, neurology and cardiovascular.
Venus is among the top 10 players in the global injectable space with only one percent of India's over 10,000 pharmaceutical companies into the injectable segment. Besides this, Venus has come up with some revolutionary products, for which the company has filed more than 360 patents worldwide and already bagged 80 patents, including patents from the US, Europe, Japan, Australia and other countries.
The company has invested in state-of-the-art laboratories equipped with sophisticated equipment and facility systems compliant with CFR and capable of generating audit trails. Venus adheres to the stringent quality control norms benchmarked with global GMP standards, thereby leading to international product quality. The awards seek to recognize exceptional initiative, pioneered manufacturing breakthroughs, developed best practices, and nurtured exceptional teams to deliver manufacturing excellence.